• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MANUFACTURING INC CLINICAL CHEMISTRY TOTAL BILIRUBIN; TOTAL BILIRUBIN REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MANUFACTURING INC CLINICAL CHEMISTRY TOTAL BILIRUBIN; TOTAL BILIRUBIN REAGENT Back to Search Results
Catalog Number 06L45-21
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/23/2018
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.
 
Event Description
The account generated false elevated architect total bilirubin of 47.17 umol/l on id 2141 that repeated 6.24 and <2 umol/l and beckman coulter method of approximately 6 to 7 umol/l.No specific patient details were provided.No impact to patient management was reported.
 
Manufacturer Narrative
A ticket search by product lot found no other complaints similar to the current complaint issue.The trend review by the product list number found no adverse or non-statistical trends related to this issue.Review of patient data in the field for the past 52 weeks suggests the total bilirubin product is performing as intended in the field.The historical performance of reagent lot 51992uq09 was evaluated using world wide data showing no unusual reagent lot performance was identified for lot 51992uq09.Labeling was reviewed and found to adequately address the issue under review.Use error may have contributed to the customer issue as a result of multiple occurrences of error code 0550 and not washing the cuvettes were found upon customer data review.In addition, the suspect results had result flags of cntl indicating a control result was out of range and that the patient results should be reviewed.No product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLINICAL CHEMISTRY TOTAL BILIRUBIN
Type of Device
TOTAL BILIRUBIN REAGENT
Manufacturer (Section D)
ABBOTT MANUFACTURING INC
1921 hurd drive
irving TX 75038
MDR Report Key8162023
MDR Text Key130337019
Report Number1628664-2018-02148
Device Sequence Number1
Product Code CIG
UDI-Device Identifier00380740011369
UDI-Public00380740011369
Combination Product (y/n)N
PMA/PMN Number
K060574
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 03/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/13/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2019
Device Catalogue Number06L45-21
Device Lot Number51992UQ09
Was Device Available for Evaluation? No
Date Manufacturer Received02/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT C16000 LIST 03L77-01; ARCHITECT C16000 LIST 03L77-01,; SERIAL (B)(4); SERIAL (B)(4)
-
-